The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 12, 2023 | Perkins Adelene Q | Director | Sell(S) | 410K | $0.07 | $29K |
| Sep 9, 2023 | Perkins Adelene Q | Director | Option exercise(M) | 768K | — | — |
| Sep 9, 2023 | Perkins Adelene Q | Director | Option exercise(M) | 768K | — | $0 |
| Aug 2, 2022 | Peluso Stephane | Chief Scientific Officer | Buy(S) | 15K | $0.66 | $10K |
| Aug 2, 2022 | Peluso Stephane | Chief Scientific Officer | Option exercise(M) | 50K | — | — |
| Aug 2, 2022 | Peluso Stephane | Chief Scientific Officer | Option exercise(M) | 50K | — | $0 |
| Jun 16, 2022 | Schwartz Brian | Director | Grant(A) | 31K | $0.68 | $21K |
| Jun 16, 2022 | Schwartz Brian | Director | Grant(A) | 45K | — | $0 |
| Jun 16, 2022 | Selby Norman C | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2022 | Selby Norman C | Director | Grant(A) | 45K | — | $0 |
| Jun 16, 2022 | Agresta Samuel | Director | Grant(A) | 45K | — | $0 |
| Jun 16, 2022 | Gaynor Richard | Director | Grant(A) | 45K | — | $0 |
| Jun 16, 2022 | Beier David W | Director | Grant(A) | 45K | — | $0 |
| Jun 16, 2022 | Evnin Anthony B | Director | Grant(A) | 46K | $0.68 | $32K |
| Jun 16, 2022 | Evnin Anthony B | Director | Grant(A) | 45K | — | $0 |
| Mar 30, 2022 | Kango Sujay | Director | Grant(A) | 90K | — | $0 |
| Jan 11, 2022 | Ilaria Robert Jr. | Chief Medical Officer | Grant(A) | 87K | — | $0 |
| Jan 11, 2022 | Peluso Stephane | Chief Scientific Officer | Grant(A) | 87K | — | $0 |
| Jan 11, 2022 | Tasker Seth A | Chief Business Officer | Grant(A) | 225K | — | $0 |
| Jan 11, 2022 | Bloch Lawrence E | President | Grant(A) | 335K | — | $0 |
| Jan 11, 2022 | Perkins Adelene Q | Chief Executive Officer, Director | Grant(A) | 576K | — | $0 |
| Sep 7, 2021 | Schwartz Brian | Director | Grant(A) | 60K | — | $0 |
| Sep 1, 2021 | Ilaria Robert Jr. | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Aug 2, 2021 | Peluso Stephane | Chief Scientific Officer | Grant(A) | 50K | — | $0 |
| Aug 2, 2021 | Peluso Stephane | Chief Scientific Officer | Grant(A) | 250K | — | $0 |
| Jun 10, 2021 | Beier David W | Director | Grant(A) | 30K | — | $0 |
| Jun 10, 2021 | Beier David W | Director | Grant(A) | 3K | $3.43 | $10K |
| Jun 10, 2021 | Evnin Anthony B | Director | Grant(A) | 3K | $3.43 | $10K |
| Jun 10, 2021 | Evnin Anthony B | Director | Grant(A) | 30K | — | $0 |
| Jun 10, 2021 | Gaynor Richard | Director | Grant(A) | 30K | — | $0 |
| Jun 10, 2021 | Selby Norman C | Director | Grant(A) | 30K | — | $0 |
| Jun 10, 2021 | Selby Norman C | Director | Grant(A) | 10K | — | $0 |
| Jun 10, 2021 | Agresta Samuel | Director | Grant(A) | 30K | — | $0 |
| May 14, 2021 | Selby Norman C | Director | Option exercise(M) | 5K | $0.92 | $5K |
| May 14, 2021 | Selby Norman C | Director | Option exercise(M) | 5K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).